Bonito peptides provide safe, effective, and natural blood pressure support for individuals with pre-hypertension (systolic blood pressure: 120-139 mmHg; diastolic blood pressure: 80-89 mmHg) or Stage 1 hypertension (systolic blood pressure: 140-159 mmHg; diastolic blood pressure: 90-99 mmHg).
In fact, there are already three human clinical trials that have been successfully conducted using bonito peptides in subjects with borderline or mild hypertension. Data has revealed significant decreases in blood pressure, with an average decrease of 10 mm Hg in systolic blood pressure and 7 mm Hg in diastolic blood pressure after several weeks of use. In a recent study, researchers used an optimized bonito peptide mixture of 1.5 grams daily.
Clinical trial research suggests that bonito peptides are approximately 64 percent effective in reducing blood pressure in borderline and mildly hypertensive subjects. In these short-term clinical trials, no adverse side effects were reported, suggesting that bonito peptides have an excellent safety profile.